Health Condition 1: F317- Bipolar disorder, currently in remission Health Condition 2: F172- Nicotine dependence Health Condition 3: F200- Paranoid schizophrenia Health Condition 4: F250- Schizoaffective disorder, bipolartype
Conditions
Interventions
Intervention1: Combined behavioural and pharmacological support intervention (IMPACT 4S intervention): Combined behavioural and pharmacological support intervention (IMPACT 4S intervention): Up to 10,
Sponsors
Prof Pratima Murthy
Dr Krishna Prasad M
Eligibility
Inclusion criteria
Inclusion criteria: Adults (>=18 years old) with SMI (i.e. schizophrenia, schizoaffective disorder, bipolar affective disorder, psychosis, severe depression with psychosis) ï?· Considered to be stable by the mental health clinical team ï?· Self-reported current smoker of any form of smoked tobacco product (including cigarettes, bidis, waterpipe etc) for at least 6 months ï?· Smoking on >25 days in the past month ï?· Able to provide informed consent ï?· Attending included institutions during the study period ï?· Willing to cut down or quit smoking ï?· Willing and able to attend up to 10 face-to-face counselling sessions ï?· Living in Bangalore urban and rural districts in India
Exclusion criteria
Exclusion criteria: Pregnant or breastfeeding women ï?· Comorbid drug and/or alcohol problems Epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcomes 1.Recruitment rates 2. Reasons for ineligibility/non-participation/non-consent of participants. 3. Length of time required to achieve the required sample size. 4. Retention in study 5. Retention in treatment 6. Intervention fidelity 7. Smoking cessation pharmacotherapy adherence 8. Data completeness Timepoint: Data will be measured and collected from participants and carers at baseline, one, three and six months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 9. Self-reported or family/carer reported continuous smoking abstinence for at least six months (only five instances of smoking allowed during the total six months) which is biochemically verified by CO concentration (CO concentration 7ppm) at six months follow-up. 10. Point abstinence, defined as a self-report or family/carer report of not smoking in the previous seven days, assessed at one, three and six months follow-up. 11. Cost of delivering the IMPACT 4S and the BA interventions.Timepoint: Data will be measured and collected from participants and carers at baseline, one, three and six months. | — |
Countries
India, Pakistan
Contacts
Public ContactProf Pratima Murthy
NIMHANS
Outcome results
None listed